Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
Exciting current CLL trials taking place in the UK
Next-generation BTK inhibitors and their value in CLL
Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.